drugset / Trial / NCT03447990
v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this Phase 1b/2a study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MYK-491 in patients with stable heart failure.
Timeline
- Start
- 2018-02-06
- Primary completion
- 2019-10-24
- Completion
- 2019-10-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Danicamtiv | Small molecule | — | Oral |